By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Karyopharm Therapeutics 



Newton  Massachusetts    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Karyopharm (KPTI) Presents Updated Phase IIb STORM Data At The American Society of Hematology 2016 Annual Meeting 12/5/2016 7:48:59 AM
Karyopharm (KPTI) Presents Updated Phase II SAIL Relapsed/Refractory AML Clinical Data At The American Society of Hematology 2016 Annual Meeting 12/5/2016 7:47:42 AM
Karyopharm (KPTI) Reports Third Quarter 2016 Financial Results And Highlights Recent Progress 11/8/2016 7:33:08 AM
Karyopharm (KPTI) To Present Updated Phase IIb STORM And Phase Ib STOMP Clinical Data At The American Society of Hematology 2016 Annual Meeting 11/3/2016 8:39:03 AM
Karyopharm (KPTI) To Ring The Nasdaq Stock Market Closing Bell 11/2/2016 8:10:15 AM
Karyopharm (KPTI) To Report Third Quarter 2016 Financial Results On November 7, 2016 10/31/2016 7:41:57 AM
Karyopharm (KPTI) To Present At The 15th Annual BIO Investor Forum 10/11/2016 8:07:47 AM
Karyopharm (KPTI) To Present Updated SIGN Phase II Clinical Data At European Society Of Medical Oncology 2016 Annual Meeting 10/5/2016 7:49:10 AM
Karyopharm (KPTI) Publishes Preclinical Data In Nature Demonstrating Selinexor’s Potential In KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC) 9/29/2016 7:42:31 AM
Karyopharm (KPTI) Publishes Preclinical And Phase 1 Clinical Data For Selinexor In Ovarian Cancer In Clinical Cancer Research Publication 9/28/2016 7:24:21 AM
12345678910...
//-->